Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19843665rdf:typepubmed:Citationlld:pubmed
pubmed-article:19843665lifeskim:mentionsumls-concept:C0684249lld:lifeskim
pubmed-article:19843665lifeskim:mentionsumls-concept:C0034802lld:lifeskim
pubmed-article:19843665lifeskim:mentionsumls-concept:C0016030lld:lifeskim
pubmed-article:19843665lifeskim:mentionsumls-concept:C0683598lld:lifeskim
pubmed-article:19843665lifeskim:mentionsumls-concept:C2267115lld:lifeskim
pubmed-article:19843665lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:19843665pubmed:issue21lld:pubmed
pubmed-article:19843665pubmed:dateCreated2009-11-5lld:pubmed
pubmed-article:19843665pubmed:abstractTextLung cancers with epidermal growth factor receptor (EGFR)-activating mutations show good clinical response to gefitinib and erlotinib, selective tyrosine kinase inhibitors (TKI) to EGFR, but these tumors invariably develop drug resistance. Host stromal cells have been found to have a considerable effect on the behavior of cancer cells. Little is known, however, about the role of host cells on the sensitivity of cancer cells to receptor TKIs. We have therefore assessed the effect of crosstalk between stromal cells and lung cancer cells harboring EGFR mutations on susceptibility to EGFR-TKIs.lld:pubmed
pubmed-article:19843665pubmed:languageenglld:pubmed
pubmed-article:19843665pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19843665pubmed:citationSubsetIMlld:pubmed
pubmed-article:19843665pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19843665pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19843665pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19843665pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19843665pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19843665pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19843665pubmed:statusMEDLINElld:pubmed
pubmed-article:19843665pubmed:monthNovlld:pubmed
pubmed-article:19843665pubmed:issn1078-0432lld:pubmed
pubmed-article:19843665pubmed:authorpubmed-author:VighB JBJlld:pubmed
pubmed-article:19843665pubmed:authorpubmed-author:SoneSaburoSlld:pubmed
pubmed-article:19843665pubmed:authorpubmed-author:MatsumotoKuni...lld:pubmed
pubmed-article:19843665pubmed:authorpubmed-author:WatanabeGoGlld:pubmed
pubmed-article:19843665pubmed:authorpubmed-author:OdaMakotoMlld:pubmed
pubmed-article:19843665pubmed:authorpubmed-author:MatsumotoIsao...lld:pubmed
pubmed-article:19843665pubmed:authorpubmed-author:NishiokaYasuh...lld:pubmed
pubmed-article:19843665pubmed:authorpubmed-author:YanoSeijiSlld:pubmed
pubmed-article:19843665pubmed:authorpubmed-author:CHUE PEPlld:pubmed
pubmed-article:19843665pubmed:authorpubmed-author:KayanoYoshiyu...lld:pubmed
pubmed-article:19843665pubmed:authorpubmed-author:YamadaTadaaki...lld:pubmed
pubmed-article:19843665pubmed:issnTypePrintlld:pubmed
pubmed-article:19843665pubmed:day1lld:pubmed
pubmed-article:19843665pubmed:volume15lld:pubmed
pubmed-article:19843665pubmed:ownerNLMlld:pubmed
pubmed-article:19843665pubmed:authorsCompleteYlld:pubmed
pubmed-article:19843665pubmed:pagination6630-8lld:pubmed
pubmed-article:19843665pubmed:meshHeadingpubmed-meshheading:19843665...lld:pubmed
pubmed-article:19843665pubmed:meshHeadingpubmed-meshheading:19843665...lld:pubmed
pubmed-article:19843665pubmed:meshHeadingpubmed-meshheading:19843665...lld:pubmed
pubmed-article:19843665pubmed:meshHeadingpubmed-meshheading:19843665...lld:pubmed
pubmed-article:19843665pubmed:meshHeadingpubmed-meshheading:19843665...lld:pubmed
pubmed-article:19843665pubmed:meshHeadingpubmed-meshheading:19843665...lld:pubmed
pubmed-article:19843665pubmed:meshHeadingpubmed-meshheading:19843665...lld:pubmed
pubmed-article:19843665pubmed:meshHeadingpubmed-meshheading:19843665...lld:pubmed
pubmed-article:19843665pubmed:meshHeadingpubmed-meshheading:19843665...lld:pubmed
pubmed-article:19843665pubmed:meshHeadingpubmed-meshheading:19843665...lld:pubmed
pubmed-article:19843665pubmed:meshHeadingpubmed-meshheading:19843665...lld:pubmed
pubmed-article:19843665pubmed:meshHeadingpubmed-meshheading:19843665...lld:pubmed
pubmed-article:19843665pubmed:meshHeadingpubmed-meshheading:19843665...lld:pubmed
pubmed-article:19843665pubmed:meshHeadingpubmed-meshheading:19843665...lld:pubmed
pubmed-article:19843665pubmed:meshHeadingpubmed-meshheading:19843665...lld:pubmed
pubmed-article:19843665pubmed:meshHeadingpubmed-meshheading:19843665...lld:pubmed
pubmed-article:19843665pubmed:meshHeadingpubmed-meshheading:19843665...lld:pubmed
pubmed-article:19843665pubmed:meshHeadingpubmed-meshheading:19843665...lld:pubmed
pubmed-article:19843665pubmed:meshHeadingpubmed-meshheading:19843665...lld:pubmed
pubmed-article:19843665pubmed:year2009lld:pubmed
pubmed-article:19843665pubmed:articleTitleCrosstalk to stromal fibroblasts induces resistance of lung cancer to epidermal growth factor receptor tyrosine kinase inhibitors.lld:pubmed
pubmed-article:19843665pubmed:affiliationDivision of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa, Japan.lld:pubmed
pubmed-article:19843665pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19843665pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19843665lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19843665lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19843665lld:pubmed